Volume 6, Issue 2 (Int J Mol Cell Med 2017)                   Int J Mol Cell Med 2017, 6(2): 66-76 | Back to browse issues page


XML Print


1- Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
2- Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
3- Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. , s.ghafourifard@sbmu.ac.ir
Abstract:   (9443 Views)

Probiotics are defined as live bacteria and yeasts that exert beneficial effects for health. Among their various effects, anti-cancer properties have been highlighted in recent years. Such effects include suppression of the growth of microbiota implicated in the production of mutagens and carcinogens, alteration in carcinogen metabolism and protection of DNA from oxidative damage as well as regulation of immune system. We performed a computerized search of the MEDLINE/PUBMED databases with keywords: cancer, probiotics, lactobacilli, metastasis, and invasion. Cell line studies as well as animal models and human studies have shown the therapeutic effects of probiotics in reduction of invasion and metastasis in cancer cells. These results support the beneficial effects of probiotics both in vitro and in vivo. However, pre-clinical or clinical studies are not enough to decide about their application.

Full-Text [PDF 571 kb]   (4432 Downloads)    
Type of Study: Review | Subject: Genomics & Proteomics and Medical Biotechnology
Received: 2017/01/31 | Accepted: 2017/03/21 | Published: 2017/05/31

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.